World Tuberculosis Drug Market to Grow at 3.17% CAGR to 2021 February 2017 Clique para ler
  • Comentários

World Tuberculosis Drug Market to Grow at 3.17% CAGR to 2021

February 2017

Publicado no e em "Negócios, Negócios", idioma — English. 2 páginas.
The latest trend gaining momentum in the tuberculosis drug market is focus on development of shorter TB drug regimens. MDR-TB needs a treatment course of second-line drugs over 18 months or more, which is quite higher than the standard six months of treatment with first-line TB drugs. Since last 5-7 years, the R&D efforts have been accelerated to reduce this elongated timeline and conventional treatment regimen for MDR-TB. Mais
According to the tuberculosis drug market report, one of the major drivers for this market is increase in outbreak of TB-HIV co-infections. The risk of developing TB is 26-32 times greater in people living with HIV than among those without HIV. HIV and TB are inter-related co-infection where one could lead to another. It is very prominent to find individuals with HIV infection along with either latent or active TB disease. Mais
Mostrar Tags
Etiquetas: tuberculosis drug
Assine GRÁTIS